Original Article
Other versions:
- ContentsContents
- Article InfoArticle Info
- CiteCite
- MetricsMetrics
- CommentComment
- RelatedRelated
- FigsFigs
- TabsTabs
- RefsRefs
- CitedCited
Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus® as a nanocarrier. Acta Marisiensis - Seria Medica 70: 42.
DOI: 10.2478/amma-2024-0011
Formulation Strategies of Nanosuspensions for Various Administration Routes. Pharmaceutics 15: 1520.
DOI: 10.3390/pharmaceutics15051520
A multi-enzymatic cascade reaction for the synthesis of bioactive C-oligosaccharides. Chinese Chemical Letters 35: 109028.
DOI: 10.1016/j.cclet.2023.109028
Nanoparticles with SGLT2 inhibitory activity: Possible benefits and future. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17: 102869.
DOI: 10.1016/j.dsx.2023.102869
Olive oil and flaxseed oil incorporating niosomes for enhanced in vivo anti-diabetic efficacy of canagliflozin . Drug Development and Industrial Pharmacy : 1.
DOI: 10.1080/03639045.2024.2409167
Enhancement of the Dissolution and Solubility of Canagliflozin Using Nanodispersion Systems . Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 6: 222.
DOI: 10.54133/ajms.v6i1.639
Poly(allylamine)-adorned heptylcarboxymethyl galactomannan nanocarriers of canagliflozin for controlling type-2 diabetes: Optimization by Box-Behnken design and in vivo performance. International Journal of Biological Macromolecules 277: 134253.
DOI: 10.1016/j.ijbiomac.2024.134253
Subscribe to email alerts for current Article's categories